{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"48.800","rs_stock_flag":false,"fiscal_year_end":"2024年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"132,670,900","primaryexch":"香港交易所","ric":"6185.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.0,"inline_upper_strike_price":"","sedol":"BJKDJS2","am":"45.95","iv":"","ew_strike":"","as":"46.960","geographic_focus":null,"incorpin":"中華人民共和國","etp_baseCur":null,"ew_amt_os":"","bd":"46.920","registrar":"香港中央證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"200","update_time":"2025-09-28 00:06:03.0","lo52":"20.400","shares_issued_date":"2025年8月31日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"K","base_currency":null,"coupon":"","expiry_date":"","chairman":"Xuefeng Yu","underlying_ric":"688185.SS","hi52":"56.550","issuer_name":"康希諾生物股份公司 - H股","h_share_flag":true,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"46.800","mkt_cap":"6.23","f_aum_hkd":null,"ew_sub_per_to":"","ls":"46.960","nav_date":"","csic_classification":"醫藥衛生","floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"-1.940","aum":"","issued_shares_class_B":null,"vo":"961.80","secondary_listing_flag":false,"listing_date":"2019年3月28日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"康希諾生物股份公司 - H股","nm_s":"康希諾生物","sym":"6185","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.020","strike_price":"","summary":"康希諾生物股份公司是一家主要從事人類用疫苗產品的研發、生產和商業化的中國公司。該公司的產品及在研產品管線涵蓋預防腦膜炎、肺炎、百白破（DTP）、新冠肺炎（COVID-19）、埃博拉病毒病、脊髓灰質炎、帶狀疱疹、結核病等多個疫苗品種。該公司還從事藥品生產工藝研究開發業務。該公司在國內和國外市場開展業務。","op":"48.800","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"生物技術","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"中國天津市<br/>經濟技術開發區西區<br/>南大街185號<br/>西區生物醫藥園四層401-420","pc":"-3.97","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"48.900","isin":"CNE100003F01","moneyness":""}},"qid":"1759074235646"}
